Report Highlights
The global market for health self-monitoring technologies should grow from $48.7 billion in 2021 to $185.9 billion by 2026 with a compound annual growth rate (CAGR) of 30.7% for the period of 2021-2026.
Report Includes
- 17 tables
- An overview of the global markets and technologies for health self-monitoring
- Estimation of the market size, and analyses of the global market trends, with data from 2019-2021, with projection of CAGR through 2026
- Identification of key market dynamics, trends, opportunities, and factors influencing the global market and highlights of the market potential for health self-monitoring market on the basis of technologies, peripherals and region
- Insights into the major stakeholders and analysis of the competitive landscape based on recent developments and segmental revenues
- Comparative study between digital vs. analog monitoring technologies, mobile vs. portable monitoring technologies, self-testing vs. self-monitoring and health vs. sports and fitness monitoring technologies, and assessment of their potential applications
- Discussion on user demographic and socioeconomic characteristics, and issues like epidemiological, legal, and regulatory issues and insights into regulatory approvals
- Evaluation of the companies best positioned to meet the current and future demand of health self-monitoring technologies owing to their proprietary technologies, strategic alliances, or other advantages
- Company profiles of the market leading participants, including Alphabet Inc., Apple Inc., Garmin Ltd., Samsung Electronics Co. Ltd., and Motorola Mobility LLC
Report Scope
This report examines the current and forecast market potential for health self-monitoring. It offers a detailed analysis of the market background, technological advancement, competitive environment, drivers and restraints, and market growth trends. This report includes market projections through 2026, detailing the market share for health self-monitoring based on the technologies.
By technologies, the health self-monitoring market is segmented into peripherals and software applications.
By geography, the health self-monitoring market has been segmented into Europe, North America, Asia-Pacific (APAC), and the Rest of the World (RoW). The detailed analyses of major countries such as the U.S., Germany, Canada, the U.K., Spain, Italy, France, Japan, India, and China are regional segments. For market estimates, data is provided for 2020 as the base year, for 2021 and forecast through year-end 2026. Estimated values used are based on health self-monitoring companies’ total revenues. Projected and forecast revenue values are in constant U.S. dollars that have not been adjusted for inflation.
The present report focuses particularly on technologies that enable individuals to monitor their health. Third-party monitoring technologies thus are specifically excluded, except to the sense that the people being monitored have direct access to the data in a form useful for self-monitoring. Apps that extract data from an individual’s EHR and format and display those data on the individual’s self-monitoring product are covered in the report, but not EHRs per se.
Report Synopsis
| Report Metrics | Details | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Base year considered | 2020 | ||||||||||||||||||||||
| Forecast period considered | 2021-2026 | ||||||||||||||||||||||
| Base year market size | $39.4 billion | ||||||||||||||||||||||
| Market size forecast | $185.8 billion | ||||||||||||||||||||||
| Growth rate | CAGR of 30.7% from 2021 to 2026 | ||||||||||||||||||||||
| Units considered | $ Millions | ||||||||||||||||||||||
| Segments covered | Technology | ||||||||||||||||||||||
| Regions covered | North America, Europe, Asia-Pacific, Rest of the World (RoW) | ||||||||||||||||||||||
| Countries covered | U.S., Canada, Germany, France, U.K, Spain, Italy, Rest of Europe, Japan, China, India, Rest of APAC | ||||||||||||||||||||||
| Key Market Drivers |
|
||||||||||||||||||||||
| Companies studied |
|
||||||||||||||||||||||
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
- Laboratory Animal Models, 3D Cultures, and Organoids: Global Markets (PHM204C)
- Global DNA Sequencing: Research, Applied and Clinical Markets (BIO045J)
- Surgical Equipment: Technologies and Global Markets (HLC154C)
- Microscopy: The Global Market (IAS017H)
- Global Chiplets Market (SMC137A)
Report Highlights
The global market for selected health self-monitoring technologies reached nearly $16.7 billion in 2016. This market should grow at a compound annual growth rate (CAGR) of 28.3% from $20.7 billion in 2017 to reach $71.9 billion by 2022.
Report Includes
- An overview the global markets and technologies for health self-monitoring.
- Analyses of global market trends, with data from 2016, estimates for 2017, and projections of CAGRs through 2022.
- Existing health self-monitoring technologies, as well as technologies that are under development.
- Analysis of major drivers and constraints that will influence the future development of the self-monitoring market.
- Projections of the market for major health self-monitoring technology platforms, devices, and software.
- Descriptions and evaluations of different vendors’ business models.
- Assessments of the potential impact of self-monitoring on the way medicine is practiced.
Report Highlights
The global market for selected health self-monitoring technologies reached $1.1 billion and nearly $3.2 billion in 2013 and 2014, respectively. This market is forecast to grow at a compound annual growth rate (CAGR) of 42.9% to reach $18.8 billion in 2019.
Report Includes
- Overview the global markets and technologies for health self-monitoring.
- Analyses of global market trends, with data from 2013 and 2014, and projections of CAGRs through 2019.
- Identify and describe existing health self-monitoring technologies, as well as technologies that are under development.
- Analyze the major drivers and constraints that will influence the future development of the self-monitoring market.
- Project the market for major health self-monitoring technology platforms, devices, and software.
- Describe and evaluate different vendors’ business models.
- Assess the potential impact of self-monitoring on the way medicine is practiced.
Related Reports
Brain-Computer Interface: Global Markets
The global market for brain computer interface (BCI) was valued at $2.1 billion in 2023. The market is expected to grow from $2.3 billion in 2024 to $4.5 billion by 2029, at a compound annual growth rate (CAGR) of 14.2% from 2024 through 2029.
Microelectronic Medical Implants: Products, Technologies & Opportunities
The global market for microelectronic medical implants is expected to grow from $49.0 billion in 2024 and is projected to reach $85.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.7% during the forecast period of 2024 to 2029.
Wearable Medical Devices: Technologies and Global Markets
The global market for wearable medical devices was valued at $35.6 billion in 2023. This market is estimated to grow from $45.0 billion in 2024 to $151.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 27.5% from 2024 through 2029.
Bioinformatics: Technologies and Global Markets
The global market for bioinformatics is expected to grow from $18.7 billion in 2023 to $35.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 13.6% during the forecast period of 2023-2028.
Recent Reports
Surgical Equipment: Technologies and Global Markets
The global market for surgical equipment and technologies was valued at $37.6 billion in 2023. This market is expected to grow from $40.0 billion in 2024 to $56.6 billion by 2029, at a compound annual growth rate (CAGR) of 7.2% from 2024 to 2029.
Conventional and Alternative Pain Treatment Markets
The global market for conventional and alternative pain treatment is expected to grow from $96.2 billion in 2024 and is projected to reach $144.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.4% during the forecast period of 2024 to 2029.
CRISPR Technology: Global Markets
The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Top Trending Reports
Single-use Technologies for Biopharmaceuticals: Global Markets
The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.
Global Market Opportunities and Competitive Landscape for CDMO
The global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Medical Devices Industry: Competitive Landscape
The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More